Trial reportScientific reports2025
Effects of Passiflora incarnata on salivary biomarkers and anxiety in patients undergoing third molar extraction surgery.
Trial report in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
This study aimed to evaluate the effectiveness of Passiflora incarnata in controlling anxiety during impacted third molar extractions, in comparison to Midazolam and placebo. Thirty healthy patients (aged 16–35) indicated for impacted third molar extraction were randomly assigned to three groups (n = 10): placebo (PLA), Midazolam (MID), and Passiflora incarnata (PAS). Medications were administered 30 min prior to surgery. Anxiety was assessed using the Corah Dental Anxiety Scale, Modified Dental Anxiety Scale (MDAS), and Hospital Anxiety and Depression Scale (HAD). Physiological parameters (heart rate, blood pressure, and oxygen saturation) were recorded pre-, intra- (at specific surgical stages), and postoperatively. Saliva samples were collected pre- and post-surgery under standardized conditions to avoid blood contamination and analyzed for cortisol (via chemiluminescence assay, expressed in µg/dl), α-amylase activity (using a spectrophotometric method, expressed in U/L), and total protein content (via BCA assay, expressed in g/L). Questionnaires were administered before and after surgery to minimize medication influence. Statistical analysis was performed using SigmaPlot 12.0, with data subjected to normality testing, two-way ANOVA, and post-hoc Holm-Sidak tests at a 5% significance level. No significant differences were observed between groups regarding anxiety scores or most physiological measures (p > 0.05). Diastolic blood pressure was higher in the PAS group (p < 0.05). Salivary cortisol levels in the PAS and MID groups were significantly lower than in PLA postoperatively (p < 0.05), with no differences between PAS and MID (p > 0.05). These findings suggest that Passiflora incarnata is a safe and effective alternative for reducing biochemical stress markers during oral surgery, despite similar effects on subjective anxiety measures.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.